{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-051090","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.468898+00:00","generated_at":"2026-05-29T00:35:16.065148+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Telomir Pharmaceuticals replaces auditor Cherry Bekaert with Salberg & Company after material weakness disclosure","bullets":["Cherry Bekaert LLP resigned as independent auditor effective Dec 16, 2024; no disagreements on accounting principles.","Auditor previously identified material weaknesses in internal control over financial reporting as of Dec 31, 2023 and 2022.","Company engaged Salberg & Company P.A. as new independent registered public accountant on Dec 18, 2024.","Prior audit reports (2022, 2023) were unqualified except for a going concern explanatory paragraph."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-051090","json":"https://secwatch.observer/filing/0001493152-24-051090.json","markdown":"https://secwatch.observer/filing/0001493152-24-051090.md","text":"https://secwatch.observer/filing/0001493152-24-051090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/0001493152-24-051090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:35:16.065148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ce0cb658ba7b445f78d2f360a2fdf6c38a039f97","claim":"Telomir Pharmaceuticals, Inc. engaged Salberg & Company P.A. as its auditor.","evidence_excerpt":"On December 18 th , 2024, the Company engaged Salberg & Company P.A. (“Salberg”) as its new independent registered public accountant for the fiscal year ending December 31, 2024.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/0001493152-24-051090-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Salberg & Company P.A."}],"fact_type":"auditor_change"},{"claim_id":"f842348af650c434464a4150d303c6414e425db8","claim":"Cherry Bekaert LLP resigned as auditor of Telomir Pharmaceuticals, Inc..","evidence_excerpt":"By letter dated December 16, 2024, Cherry Bekaert LLP (“Cherry Bekaert”) notified the Audit Committee of the Board of Directors (the “Audit Committee”) of Telomir Pharmaceuticals, Inc’s (the “Company”) of its resignation as the Company’s independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/0001493152-24-051090-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"Cherry Bekaert LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}